US EditionPublished • loading... • Updated
Nobel Prize-Winning Scientist's Bombastic Announcement: What Used to Take Decades Could Be Shortened to Weeks
Summary by Portfolio
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Demis Hassabis, founder and CEO of Isomorphic Labs, acknowledged in Davos on Tuesday that the first clinical trials of the company's artificial intelligence-based development are not expected to begin until late 2026, Reuters reported. This is a shift from the company's previous, more ambitious plans, which had expected a launch in 2025.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
